The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sunnybrook.ca

Founded Year

1948

Stage

Series A | Alive

Total Raised

$710K

Last Raised

$710K | 2 yrs ago

About Sunnybrook Research Institute

Sunnybrook Research Institute (SRI) is a fully affiliated research and teaching hospital with the University of Toronto. Research spans three Toronto-based campuses: Sunnybrook Health Sciences Centre, Holland Centre and St. John's Rehab.

Sunnybrook Research Institute Headquarter Location

2075 Bayview Avenue

Toronto, Ontario, M4N 3M5,

Canada

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sunnybrook Research Institute Patents

Sunnybrook Research Institute has filed 88 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Acoustics
  • Medical ultrasonography
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/27/2017

5/3/2022

Medical imaging, Spectroscopy, Medical equipment, Fiber optics, Medical ultrasonography

Grant

Application Date

2/27/2017

Grant Date

5/3/2022

Title

Related Topics

Medical imaging, Spectroscopy, Medical equipment, Fiber optics, Medical ultrasonography

Status

Grant

Latest Sunnybrook Research Institute News

Conavi Medical’s Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre

Apr 28, 2022

Author of the article: Article content Sunnybrook’s Schulich Heart Program to provide the latest innovative hybrid imaging of coronary arteries for complex cases We apologize, but this video has failed to load. Try refreshing your browser, or Conavi Medical's Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre Back to video TORONTO — Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program. Sunnybrook’s Schulich Heart Program is one of Canada’s leading cardiac and vascular care centres with an international reputation for pioneering some of the world’s most innovative ways to diagnose and treat the heart and damaged blood vessels. Advertisement 2 Article content The hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging platform, now called Novasight Hybrid System, was initially invented at Sunnybrook Research Institute (SRI) by Dr. Brian Courtney, a scientist and interventional cardiologist. It is the first and only clinical system available on the market that enables simultaneous and co-registered imaging of coronary arteries with both IVUS and OCT to help physicians visualize disease and deploy stents to open the arteries and restore blood flow in percutaneous coronary interventions (PCIs). “At Sunnybrook, we are continually striving to bring personalized and precise diagnostics and treatments to our patients. In fact, it’s a key part of our strategic plan,” said Andy Smith, President and CEO of Sunnybrook Health Sciences Centre. “Novasight is one of the many innovative tools that Sunnybrook is working on to help us achieve our goal, and we couldn’t be more proud to use this Canadian-developed technology.” The Schulich Heart Program provides comprehensive cardiac and vascular care for some of the most complex cases in Ontario. From prevention to acute intervention and long-term management, the Program addresses the greatest health challenges in all areas of the heart and vascular systems. “Having both a technical and clinical care background, this hybrid system was invented based on a combination of intensive research activities in image guided therapy and clinical needs identified during patient care. I saw an opportunity to improve imaging for minimally invasive heart procedures by creating a hybrid system that combines IVUS and OCT imaging, rather than having to choose one or the other,” said Dr. Brian Courtney, interventional cardiologist at Sunnybrook Health Sciences Centre and chief medical officer and co-founder, Conavi Medical. “After years of development, it is incredibly rewarding to now be using this advanced and pragmatic technology at Sunnybrook, where it all started. The versatility of the system has already proved useful in a variety of complex cases, such as multi-vessel disease, heavy calcification, and cases where intravascular lithotripsy was used, allowing for better patient outcomes.” Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration, and regulatory approval for clinical use from Health Canada, and the Ministry of Health, Labor and Welfare (MHLW) in Japan. Advertisement 3 Article content About Conavi Medical Conavi Medical Inc., is a privately-held company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Company’s patented hybrid intravascular imaging system is the first and only of its kind to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Conavi is focused on driving adoption of its advanced imaging solution. For more information, visit http://www.conavi.com/ . About Sunnybrook Health Sciences Centre Sunnybrook Health Sciences Centre is inventing the future of health care for the 1.3 million patients the hospital cares for each year through the dedication of its more than 16,000 staff, physicians, volunteers and learners. From our beginnings as a hospital for Canadian veterans, Sunnybrook has flourished into an internationally recognized leader in research and education with a full affiliation with the University of Toronto. Sunnybrook specializes in caring for high-risk pregnancies, veterans, critically-ill newborns and adults, offering specialized rehabilitation and treating and preventing cancer, cardiovascular disease, neurological and psychiatric disorders, orthopaedic and arthritic conditions and traumatic injuries. Sunnybrook’s over 200 scientists and clinician-scientists conduct more than $100 million in breakthrough research each year. View source version on businesswire.com: https://www.businesswire.com/news/home/20220428005153/en/ Contacts

Sunnybrook Research Institute Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sunnybrook Research Institute Rank

  • When was Sunnybrook Research Institute founded?

    Sunnybrook Research Institute was founded in 1948.

  • Where is Sunnybrook Research Institute's headquarters?

    Sunnybrook Research Institute's headquarters is located at 2075 Bayview Avenue, Toronto.

  • What is Sunnybrook Research Institute's latest funding round?

    Sunnybrook Research Institute's latest funding round is Series A.

  • How much did Sunnybrook Research Institute raise?

    Sunnybrook Research Institute raised a total of $710K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.